CVRx | Barostim
Avatar

Baroreflex Activation Therapy in Heart Failure

By CVRx | Barostim FEATURING Michael Gold, Bradley Knight, Thomas Deering, Larry Chinitz
By CVRx | Barostim FEATURING Michael Gold, Bradley Knight, Thomas Deering, Larry Chinitz
178 views
January 27, 2021
Dr. Michael Gold describes the role of autonomic modulation for the treatment of heart failure and the Barostim MOA.
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
18:36
CVRx | Barostim

Barostim and the Window of Opportunity in Class II/III HFrEF Patient…

Feat. W. Abraham, G. Panjrath, D. Yaranov, P. Mccann
09:58
CVRx | Barostim

Barostim for HFrEF Patients

Feat. P. Mccann
10:18
CVRx | Barostim

New Insights from the BeAT-HF Clinical Study

Feat. W. Abraham
06:16
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT

Feat. D. Yaranov
12:16
CVRx | Barostim

HFSA 2023: Window of Opportunity – Who and When

Feat. G. Panjrath
16:32
CVRx | Barostim

ESC 2023: BeAT-HF: Long term outcome

Feat. M. Zile
11:49
CVRx | Barostim

ESC 2023: Unmet needs and opportunities with device therapies of HFr…

Feat. W. Abraham
11:43
CVRx | Barostim

ESC 2023: Real-world experience with Baroreflex Activation Therapy

Feat. F. Arribas
06:23
CVRx | Barostim

ESC 2023: Baroreflex Activation Therapy for HFrEF Patients: Long-Ter…

Feat. W. Abraham, F. Arribas, M. Zile
16:00
CVRx | Barostim

HFA 2023: BeAT-HF: Long-Term Safety Profile and Outcomes

Feat. F. Zannad
12:14
CVRx | Barostim

HFA 2023: Challenges and Unmet Needs in GDMT for HFrEF

Feat. J. Lindenfeld
07:42
CVRx | Barostim

HFA 2023: Autonomic Dysfunction in HFrEF

Feat. M. Fudim
18:26
CVRx | Barostim

HFA 2023: Unlocking the Potential of Baroreflex Activation in Heart …

Feat. F. Zannad, J. Lindenfeld, M. Fudim
10:51
CVRx | Barostim

VAM 2023: Baroreflex Activation Therapy - A Novel Extravascular Proc…

Feat. M. PEREZ-IZQUIERDO
07:52
CVRx | Barostim

VAM 2023: Baroreflex Activation Therapy - A Novel Extravascular Proc…

Feat. C. Darling
06:59
CVRx | Barostim

VAM 2023: Baroreflex Activation Therapy - A Novel Extravascular Proc…

Feat. C. Darling, M. PEREZ-IZQUIERDO
10:51
CVRx | Barostim

Our Experience with Barostim in over 40 Patients to Date

Feat. P. Mccann
14:36
CVRx | Barostim

Barostim in the EP's HFrEF Toolbox

Feat. R. Alimohammad
09:39
CVRx | Barostim

Unmet Needs and Device Therapies in HFrEF

Feat. J. Singh
18:26
CVRx | Barostim

HFA 2023: Unlocking the Potential of Baroreflex Activation in Heart …

Feat. F. Zannad, J. Lindenfeld, M. Fudim
09:58
CVRx | Barostim

Barostim for HFrEF Patients

Feat. P. Mccann
18:36
The Texas Heart Institute

Rhythm vs Rate: Has the Tide Changed Since the AFFIRM Trial?

Feat. M. Razavi
06:59
CVRx | Barostim

VAM 2023: Baroreflex Activation Therapy - A Novel Extravascular Proc…

Feat. C. Darling, M. PEREZ-IZQUIERDO
11:43
CVRx | Barostim

ESC 2023: Real-world experience with Baroreflex Activation Therapy

Feat. F. Arribas
16:00
CVRx | Barostim

HFA 2023: BeAT-HF: Long-Term Safety Profile and Outcomes

Feat. F. Zannad
07:52
CVRx | Barostim

VAM 2023: Baroreflex Activation Therapy - A Novel Extravascular Proc…

Feat. C. Darling
07:42
CVRx | Barostim

HFA 2023: Autonomic Dysfunction in HFrEF

Feat. M. Fudim
18:36
CVRx | Barostim

Barostim and the Window of Opportunity in Class II/III HFrEF Patient…

Feat. W. Abraham, G. Panjrath, D. Yaranov, P. Mccann
18:00
ACC 2023 Conference Coverage

ACC 2023: Catch Them Before They Fall - Syncope Guidelines in Action

Feat. B. Olshansky
06:23
CVRx | Barostim

ESC 2023: Baroreflex Activation Therapy for HFrEF Patients: Long-Ter…

Feat. W. Abraham, F. Arribas, M. Zile
11:49
CVRx | Barostim

ESC 2023: Unmet needs and opportunities with device therapies of HFr…

Feat. W. Abraham
06:16
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT

Feat. D. Yaranov
16:32
CVRx | Barostim

ESC 2023: BeAT-HF: Long term outcome

Feat. M. Zile
11:23
CVRx | Barostim

Baroreflex Activation Therapy: What Has Real-World Experience Taught…

Feat. J. Bauersachs
11:51
CVRx | Barostim

Unlocking the Potential of Baroreflex Activation Therapy (BAT) for H…

Feat. M. Fudim, J. Bauersachs, W. Abraham
11:59
CVRx | Barostim

Patient Identification to Follow-up And New Implant Approach

Feat. J. Allred
12:31
CVRx | Barostim

Baroreflex Activation Therapy: What Have We Learned From Clinical Tr…

Feat. W. Abraham
12:21
CVRx | Barostim

Baroreflex Activation Therapy Overview of Clinical Data

Feat. L. Tsao
08:37
CVRx | Barostim

Baroreflex Activation Therapy (BAT) for the Treatment of HFrEF

Feat. M. Zile